Challenges in generating costs and utilisation rates associated with castration-resistant prostate cancer

Siobhan Bourke, Richéal Maria Burns, Caroline Gaynor

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Abstract

Background: Prostate cancer (PCa), the most commonly diagnosed cancer among men in the United States and Europe, is an escalating resource allocation issue across healthcare systems in the Western world. The impact of skeletal-related events, associated with castration-resistant prostate cancer (CRPC), is considerable with many new therapies being sought to treat these events in a cost-effective manner. Aims: The aim of this paper is to provide insight into the level of constraints associated with devising cost frameworks for economic analysis of CRPC in the Irish healthcare setting. Methods: An informal questionnaire was devised to obtain estimates of utilisation to populate a decision tree model; existing parameters from the literature were also employed. Cost parameters included Irish reference costs, and a costs literature review was undertaken; a healthcare payer perspective was adopted. Pharmacy dosages used for modelling costs were calculated for an average 75 kg male. Results: The estimated average cost of care associated with adverse events in CRPC was €23,264. Approximately 40% of the costs of CRPC are attributed to skeletal-related events; therefore, reducing the number of skeletal-related events could significantly reduce the cost of care. In attempting to generate accurate and reliable cost parameters, this study highlights the challenges of conducting economic analysis in the Irish healthcare setting. Conclusion: This study presents leading treatments and associated costs for CRPC patients in the Republic of Ireland (RoI), which are expected to steadily increase with demographic shifts. Further research is warranted in this area due to the limitations encountered in the study.

Original languageEnglish
Article number24072
JournalJournal of Market Access and Health Policy
Volume2
Issue number1
DOIs
Publication statusPublished - 2014
Externally publishedYes

Keywords

  • costs
  • health economics
  • prostate cancer
  • skeletal-related adverse events

Fingerprint

Dive into the research topics of 'Challenges in generating costs and utilisation rates associated with castration-resistant prostate cancer'. Together they form a unique fingerprint.

Cite this